Drugs / H7N9 A/Anhui/13 ca influenza virus vaccine
H7N9 A/Anhui/13 ca influenza virus vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02151344 | May 2014 → Feb 2015 | swine influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H7N9 A/Anhui/13 ca influenza virus vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02151344 ↗ |
| Modality | Vaccine | “Live Influenza A Vaccine H7N9 (6-2) AA ca Recombinant” NCT02151344 ↗ |
| Route | Intranasal | “the vaccine will be administered with a nose spray device” NCT02151344 ↗ |